Immunological features in patients with pneumonitis due to influenza a H1N1 infection

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 1, 2011, Pages 44-50

  Wen, Y ^a   Deng, B C ^a   Zhou, Y ^a   Wang, Y ^a   Cui, W ^a   Wang, W ^a   Liu, P ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cytokines; Immunological features; Influenza A H1N1; Pneumonitis

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; OSELTAMIVIR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LUNG FIBROSIS; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTOPENIA; MALE; PATIENT CODING; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; PROTEIN SECRETION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LYMPHOPENIA; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79951896164     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Smits SL, de Lang A, van den Brand JM, Leijten LM, van Ijcken W F, Eijkemans MJ et al. Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human Primates. PLoS Pathog. 2010; 6(2):e1000756.
2. Peiris JSM, Lai ST, Poon LLM, Guan Y, Yam LYC, Lim W, Nicholls J, Yee WKS et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003a;361:1319-25.
3. Leong HN, Earnest A, Lim HH, Chin C F, Tan CS, Puhaindran ME, Tan AC, Chen MI, Leo YS. SARS in Singapore-predictors of disease severity. Ann Acad Med Singapore. 2006;35(5):326-31.
4. Wang J T, Sheng WH, Fang C T, Chen YC, Wang JL, Yu CJ et al. Clinical manifestations, laboratory fi ndings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10(5):818-24.
5. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R et al; California Pandemic (H1N1) Working Group. Factors associated with death or hospitalization due to pandemic 2009 infl uenza A(H1N1) infection in California. JAMA. 2009 302(17): 1896-902.
6. Pérez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E et al; INER Working Group on Infl uenza. Pneumonia and Respiratory Failure from Swine-Origin Infl uenza A (H1N1) in Mexico. N Engl J Med. 2009; 361(7):680-9.
7. Gómez-Gómez A, Magaña-Aquino M, Garcia-Sepúlveda C, Ochoa-Pérez UR, Falcón-Escobedo R, Comas-García A et al. Severe pneumonia associated with pandemic (H1N1) 2009 outbreak. San Luis Potosí, Mexico. Emerg Infect Dis 2010; 16(1):27-34.
8. Chen KF, Gaydos C, Rothman RE. Update on emerging infections: news from the Centers for Disease Control and Prevention. Hospitalized patients with novel infl uenza A (H1N1) virus infection-California, April-May, 2009. Ann Emerg Med. 2009; 54(5):732-6.
9. Rello J, Rodríguez A, Ibañez P, Socias L, Cebrian J, Marques A et al; H1N1 SEMICYUC Working Group. Intensive care adult patients with severe respiratory failure caused by Infl uenza A (H1N1)v in Spain. Crit Care. 2009; 13(5):R148.
10. Echevarría-Zuno S, Mejía-Aranguré JM, Mar-Obeso AJ, Grajales-Muñiz C, Robles-Pérez E, González-León M et al. Infection and death from infl uenza A H1N1 virus in Mexico: a retrospective analysis. Lancet. 2009; 374(9707): 2032-3.
11. Hung IF, Cheng VC, Wu AK, Tang BS, Chan KH, Chu CM et al. Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis.2004;10(9):1550-7.
12. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN et al. Fatal outcome of human infl uenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006; 12:1203-7.
13. Bernabei P, Coccia EM, Rigamonti L, Bosticardo M, Forni G, Pestka S et al. Interferon-gamma receptor 2 expression as the deciding factor in human T, B, and myeloid cell proliferation or death. J Leuko Biol. 2001;70: 950-60.
14. Sobek V, Balkow S, Korner H, Simon MM. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes. Eur J Immunol. 2002; 32:2490-99.
15. Jendro MC, Fingerle F, Deutsch T, Liese A, Köhler L, Kuipers JG. Chlamydia trachomatis-infected macrophages induce apoptosis of activated T cells by secretion of tumor necrosis factor-alpha in vitro. Med Microbiol Immunol. 2004;193(1):45-52.
16. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007; 370(9593): 1137-45.
17. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN et al. Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect. 2010; 60(2):168-74.
18. To KK, Hung I F, Li IW, Lee KL, Koo CK, Yan WW et al. Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection. Clin Infect Dis. 2010; 50(6):850-9.
19. Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W et al. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004; 72:4410-5.
20. Wong CK, Lam CWK, Wu A KL, Ip WK, Lee NLS, ChanI HS et al. Plasma inflammatory cytokines and chemokines in severe respiratory syndrome. Clin Exp Immunol. 2004; 136: 95-103.
21. Fudala R, Krupa A, Stankowska D, Allen TC, Kurdowska AK. Anti-interleukin-8 autoantibody:interleukin-8 immune complexes in acute lung injury/acute respiratory distress syndrome. Clin Sci (Lond). 2008; 114(6):403-12.
22. Tang NL, Chan PK, Wong CK, To K F, Wu AK, Sung YM et al. Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem. 2005; 51(12):2333-40.
23. Huang KJ, Su IJ, Theron M, Wu YC, Lai SK, Liu CC. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005; 75(2):185-94.
24. Roberts AB, Tian F, Byfield S D, Stuelten C, Ooshima A, Saika S et al. Cytokine Growth Factor Rev. 2006; 17:19-27
25. Krein PM, Winston BW. Roles of insulin-like growth factor and transforming growth factor-beta in fibrotic lung disease. Chest 122:289S-293S. J Biomed Sci. 2002; 11:117-26.
26. Zhao X, Nicholls JM, Chen YG. Severe acute respiratory syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-beta signaling. J Biol Chem. 2008; 283(6):3272-80.
27. Pang BS, Wang Z, Zhang LM, Tong ZH, Xu LL, Huang XX et al. Dynamic changes in blood cytokine levels as clinical indicators in severe acute respiratory syndrome. Chin Med J. 2003;116: 1283-7.
28. Nicholls JM, Poon LL, Lee KC, Ng W F, Lai S T, Leung CY et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003, 61:1773-8
29. Ketai L, Paul NS, Wong KT. Radiology of severe acute respiratory syndrome (SARS): the emerging pathologic-radiologic correlates of an emerging disease. J Thorac Imaging. 2006; 21(4):276-83.
30. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM et al. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol.2005; 166: 1321-2.